Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02454426 Withdrawn - Clinical trials for Coronary Artery Disease

Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease

Start date: April 2016
Phase: Phase 0
Study type: Interventional

This is a preliminary, open-label, clinical trial designed to assess the efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients with coronary artery disease. In addition, the study will assess the effects of vortioxetine on heart rate variability in these patients.

NCT ID: NCT02453633 Not yet recruiting - Sleep Disorders Clinical Trials

Theory Based SMS Reminders - Text's Impact on Patient Attendance

Start date: May 2015
Phase: N/A
Study type: Interventional

The project will be done at the ear, nose and throat outpatient department at Lovisenberg Diakonale Hospital (LDS) in 2015-2016. About 12% of patients with appointments at the surgical outpatient clinic at LDS do not attend their appointment even after receiving both letters and shot message service (SMS) reminders. Persuasion theory suggests that the SMS reminders may be more effective if the text appeals more to the patient's feelings. The project is designed as a randomized controlled trial in which the control group receives the standard text that has neutral content and the intervention group receives a more emotion-based SMS reminder. The aim is to determine whether the more emotional text reduces the proportion of patients who do not show up for their scheduled appointment at the surgical outpatient clinic.

NCT ID: NCT02453438 Completed - Depression Clinical Trials

Mood Patient Powered Research Network (MoodNetwork)

Start date: March 2015
Phase:
Study type: Observational [Patient Registry]

The MoodNetwork, a patient-powered research network (PPRN), is one of 18 PPRNs participating in Patient-Centered Outcomes Research Institute's (PCORI) PCORnet network. Its objective is to improve the nation's capacity to conduct comparative effectiveness research that reflects questions of greatest importance to patients and other stakeholders. A robust data infrastructure will be built that, in phase one, allows participants to contribute data, including those from participant questionnaires, visualize their own health information in intuitive and helpful ways, and share their aggregated de-identified health information within and outside of the Network.

NCT ID: NCT02453217 Completed - Schizophrenia Clinical Trials

The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial

CHIP
Start date: March 31, 2016
Phase: N/A
Study type: Interventional

The investigators programme of research will evaluate an existing physical health care screening intervention with the aim of helping Community Psychiatric Nurses (CPN) to improve the physical health wellbeing of people with a SMI. This pilot clustered randomised controlled trial aims to establish the potential efficacy and acceptability of the Chinese Health Improvement Profile (CHIP) in improving the physical health of people with severe mental illness.

NCT ID: NCT02452892 Completed - Depression Clinical Trials

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the relative effectiveness of 20 and 60 minutes of Low-Field Magnetic Stimulation in relieving symptoms in patients with major depression who are treatment resistant.

NCT ID: NCT02452606 Recruiting - Parkinson Disease Clinical Trials

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the genetic variants of clock and narcolepsy genes that determine the therapeutic effects of Stalevo® on the quality of sleep in patients with Parkinson's Disease.

NCT ID: NCT02452411 Completed - Clinical trials for Adjustment Disorders

Efficacy of Two Ways of Applying Homework Assignments in the Treatment of Adjustment Disorders

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the differential efficacy of two ways of applying homework assignments in the treatment of Adjustment Disorders: 1) using an Internet-based emotional regulation therapy system (TEO) and 2) in the traditional way (using reading and audio materials). The principal hypothesis is that both treatment conditions (TEO and Traditional) will show a similar efficacy. All participants will improve significantly on all outcome measures, regardless the type of homework assigned (TEO or Traditional) with no differences between them.

NCT ID: NCT02452216 Completed - Brain Cancer Clinical Trials

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Start date: June 10, 2015
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial study will assess the inflammatory response of brain tumors or other central nervous system conditions in pediatric and adult patients using ferumoxytol-enhanced MRI. Imaging features will be correlated with the number of inflammatory cells (macrophages) at histopathology. Determining the extent of inflammation associated with pathologies in the central nervous system may be helpful for diagnostic and prognostic purposes as well as monitoring treatment response of current and future immunotherapies.

NCT ID: NCT02451670 Completed - Schizophrenia Clinical Trials

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

SMIWizard
Start date: January 20, 2016
Phase: N/A
Study type: Interventional

This purpose of this study is to adapt, implement and test the ability of a sophisticated point-of-care electronic health record-based clinical decision support that identifies and prioritizes all available evidence-based treatment options to reduce cardiovascular risk in patients with serious mental illness.

NCT ID: NCT02450695 Withdrawn - Clinical trials for Obsessive-Compulsive Disorder

rTMS in Treatment Refractory Obsessive-Compulsive Disorder

Start date: July 2016
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of rTMS as a potential treatment for refractory OCD in a randomized, crossover design.